Member Info for beinthelead

How have you arrived at this conclusion? What do you mean?

Last updated 6th April - has something happened with this?

Bang on sleepydave.

Change your broker. Can buy in volume currently.

Doggy - I totally agree, testing SHOULD be required. Especially in these settings.

BUT - the risk and attitude now toward it, means it is no longer a requirement.

Meds required. Taken. Time for a sleep. Permanent vacation.

Thanks.

:) I was aware it sounded like that.

Fully aware that the US sites online will contribute to P1a, but the comment was relating to EXPANSION which is P1b.

Expansion in 1a? Fair enough.

Expansion in 1b?

Yes, agreed. Likely see US sites. But the timing of any escalation news is unknown.

We have no idea. The newest Twitter view is that we may never see one. Which, I believe is a mega ramp and an excuse.

The only thing we have is the trial is continuing. We need to wait.

Wyn

You spread FUD. Let’s make that clear. This can be verified by a large majority on here.

I too have been accused of being a troll and a dodgy trader by RAH (Oneknows on here). I’ve never sold a single share unfortunately. If I did, i could have multiplied my holding. My criticism is not linked to a trading strategy as yours is. You’ve admitted this in the past.

I have posted on here and SBTX. The two AIM stocks I held. I sold SBTX because their strategy is flawed and the product I believe will never be a marketable success. LFE from here, you’d suggest.

My investment strategy is not very clever. I’ve got a load of this stock, blue chip, and property. I don’t chase other stocks. Don’t spend time posting on boards of shares I don’t own - yes, you’ll find this concept odd.

We’ll do what we do between now and news. Hopefully it’s good news.

Wyn - you attach yourself to popular stock and trade them on sentiment you aim to manipulate on these BB’s. This is not paranoia, or a stretch. To be fair, it’s a strategy, and you may be winning. Crack on. I certainly disagree with it.

Those still holding should be used to the wait. Timelines have been atrocious.

Those in for news should expect July, so plenty of time for it to either settle, trades execute elsewhere, a further drop.

We’re in limbo. What’s very clear to me is that the market is expecting things to run past July. We’re 8 weeks away from AS’s PK date (7months late) and we still have 1 DE, and a couple of active sites.

Little reason to buy or sell.

Holding firmly whilst offering perfectly timed SP predictions for the good of the BB community?

Makes zero sense, but each to their own.

This gem:

It hits the ceiling @140 and bounces back down. It broke out @50 on news that the Animal division had been sold off, it flew to the resistance level @140 and is now retracing. With data still incoming from AVA6000 I expect this to settle down somewhere between the breakout price and the resistance level. If it settles higher, there could be good news coming from the AVA6000 data.

Holding firmly.

Why hold if you PREDICTED it was hitting 100, regardless of news? ODX is the Covid stock. Nothing to see here.

Certainly tiresome. Nothing personal against them - I just don’t get it. Avacta don’t need any cheerleaders. If we’re led to believe AS, we have data and they’re still carrying on. That’s the best news we have to date.

Ah…. But…. Like all good traders, they recoup their losses within the next few trading sessions.

Until we’re very popular, we’ll have those that talk it up and those that con the sellers. Remember the proper trolling days? Snoop and the likes. Thankfully those days seem to be behind us.

Not a trading stock?? You having a laugh. Your posting history is an almanac for trading propaganda.

There’ll be some wealthy people made out of trading this stock. It’s like clockwork.

Many talking about ‘value disconnects’ and ‘chance of success’. The SP is not following either. It’s trading sentiment and praying on the nervousness around timescales.

For the record, the SP had LFT revenue priced in at the time of first dosing. To compare todays price vs that, in terms of measuring CoS is misleading.